Connect with us


Supreme Pharmaceuticals Inc (CVE:FIRE) Finalizes Deal With ABLE BC



Supreme Pharmaceuticals Inc (CVE:FIRE) has finalized a Letter of Intent with the Alliance of Beverage Licensees, the advocacy firm exhibiting BC’s private liquor industry. Jeff Guignard, the Executive Director of ABLE BC, expressed that they are delighted to associate with Supreme Pharmaceuticals as their first licensed supplier and producer for their retail members.

The details

British Columbians have a keen appreciation and awareness for exceptional cannabis. It was vital to select a firm devoted to growing premium cannabis at-scale. They are assured Supreme Pharmaceuticals’ product offerings are what their adult-use customers are seeking for. ABLE BC agrees to offer Supreme with innovative channels of exposure to its over 1,000 members comprising of private liquor stores, bars/nightclubs, hotel liquor licensees and neighborhood pubs.

John Fowler, the CEO of Supreme, expressed that they are thrilled to associate with ABLE BC and start a conversation with their 1,000 members. They feel strongly their concentration on premium dried cannabis flower marks as a differentiating element for Supreme Pharmaceuticals in the adult-use market, especially in BC’s quality-focused customer market.

In unrelated news, Supreme Pharmaceuticals reported that 7ACRES has started production in the newly established flowering rooms recently permitted by Health Canada. In the first week of November, more than 3,000 crops of a specially chosen phenotype of cannabis named “Wappa” were manually transplanted into the initial of three 10,000 square feet flowering rooms.

Wappa was chosen for the inaugural cropping following its favorable early-stage market feedback, terpene content and growth characteristics. The transplanting was done in a single-day procedure, required to warrant the consistency of the end product. Supreme comes in the group of Canadian publicly traded firms committed to becoming a major distributor and cultivator of sun cultivated cannabis via its 100% owned subsidiary unit 7ACRES, which is a federally approved LP of medicinal cannabis.

*Past performance is not a predictor of future results. All investing involves risk of loss and individual investments may vary. The examples provided may not be representative of typical results. Your capital is at risk when you invest – you can lose some or all of your money. Never risk more than you can afford to lose.By submitting your information you agree to the terms of our Privacy Policy • Cancel Newsletter Any Time.This is a FREE service from Finacials Trend. Signing up for our FREE daily e-letter also entitles you to receive this report. We will NOT share your email address with anyone.